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Abstract
Background: Human infants are frequently hospitalized due to infection with the paramyxovirus respiratory
syncytial virus (RSV). However, very little is known about the neonatal response to paramyxoviral infection. Here, a
neonatal model of paramyxoviral infection is developed using the mouse pathogen Sendai virus (SeV).
Results: Adult mice infected with SeV developed a predominantly neutrophilic inflammatory cell influx and a
concomitant reduction in lung function, as determined by oxygen saturation. In contrast, neonates with SeV had
significantly reduced inflammation and normal lung function. Surprisingly, infected neonates had similar viral loads
as adult mice. A reduced neutrophil influx in the neonates may be due in part to reduced expression of both
CXCL2 and intracellular adhesion molecule-1 (ICAM-1). Expression of IFN-g and TNF-a increased in a dose-
dependent manner in adult lungs, but neonates did not increase expression of either of these cytokines, even at
the highest doses. Importantly, the expression of the RIG-I-like receptors (RLRs) was delayed in the neonatal mice,
which might have contributed to their reduced inflammation and differential cytokine expression.
Conclusions: Neonatal mice developed similar SeV titers and cleared the virus with similar efficiency despite
developing a dramatically lower degree of pulmonary inflammation compared to adults. This suggests that
inflammation in the lung may not be required to control viral replication. Future studies will be needed to
determine any effect the reduced inflammation may have on the development of a protective memory response
in neonates.
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Background
Acute respiratory infection is the leading cause of mor-
tality in young children, accounting for 20% of child-
hood deaths worldwide [1]. The most common viral
respiratory pathogen in infants and children is the para-
myxovirus respiratory syncytial virus (RSV). RSV
induces a clinically significant bronchiolitis in human
infants, which may result in hospitalization [2]. Hospita-
lization rates are highest for infants between 3 and 6
months of age, whereas infants less than 1 month of age
have the lowest rate of RSV hospitalization [3]. This
m a yb ed u et or e d u c e de x p o s u r ei nt h i sa g er a n g eo r
due to decreased severity of respiratory disease as some
studies suggest that the youngest infants infected with
RSV may be asymptomatic [4,5]. The increased suscept-
ibility to respiratory viral infection in infants is attribu-
ted to deficiencies in both the innate and adaptive
immune responses (reviewed in ([6,7]) respectively).
Despite the fact that infants are the most at risk popu-
lation for serious respiratory viral infection, the neonatal
immune response to RSV is poorly understood. During
the 1960s, an attempt to develop a vaccine for RSV
failed when the infants that received the vaccine devel-
oped enhanced respiratory disease upon subsequent
infection [8]. Since that time, there have been many stu-
dies of RSV infection in adult animals but relatively few
studies examining RSV and paramyxoviral infection in
neonates (reviewed in [9]). Here we describe the
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virus Sendai virus (SeV). When compared to adult ani-
mals, newborn mice developed similar SeV titers and
cleared the virus with similar efficiency despite develop-
ing a dramatically lower degree of pulmonary inflamma-
tion. These observations, together with recent studies by
others using RSV and pneumonia virus of mice (PVM),
s u g g e s tt h a ti n f l a m m a t i o ncan be decoupled from viral
clearance and may necessitate a reassessment of the
paradigm of immune responses to RSV infection in
human infants [10,11].
Results
Six eight-week old adult C57BL/6 mice and postnatal
day 2 neonatal C57BL/6 mice were infected with 500
pfu/g body weight SeV via intranasal inoculation. The
virus was administered in a volume of 30 μlf o rt h e
adult mice, and 6 μl for the neonatal mice. Control
groups were inoculated with an equivalent amount of
SeV that was inactivated by exposure to ultraviolet light.
Infection of adult mice with SeV resulted in body weight
loss that peaked at day 9 post-infection. The adult mice
t h e nb e g a nt or e g a i nw e i g h to np o s t - i n f e c t i o nd a y1 2 .
This weight loss was not observed in adult mice inocu-
lated with UV-inactivated SeV (Figure 1a). In contrast
to the adults, the neonatal mice were in a period of
r a p i dg r o w t h .A tt h e5 0 0p f u / gb o d yw e i g h td o s eo f
SeV, there was no difference in body weight in the
infected neonates compared to the UV-inactivated con-
trol group (Figure 1b).
Infectious virus in lung homogenates was quantified
by viral plaque assay (Figure 1c). There was an equiva-
lent level of virus per gram of lung tissue in the adults
and neonates at 24 hours post-infection, which demon-
s t r a t e dt h a tt h em i c ew e r einfected with equivalent
doses of virus per gram of body weight. Viral replication
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Figure 1 Adult and neonatal mice displayed differential body weight patterns during viral infection, but had a similar viral load in the
lung. a) 6-8 week old C57BL/6 adult mice (n = 21) were inoculated intranasally with 500 pfu/g body weight SeV in sterile PBS (black squares).
The control group was inoculated with an equivalent amount of UV inactivated SeV (white squares). b) Neonatal C57BL/6 mice (n = 31) were
infected on postnatal day 2 with 500 pfu/g body weight SeV (black squares) or with UV-SeV (white squares). c) Viral plaque assay of whole lung
homogenates was performed, and pfu/ml was normalized to weight of the lung tissue (g). d) Real-time PCR for SeV was performed on whole
lung RNA. SeV expression was normalized to GAPDH and percent expression was calculated by the 2(-Delta Delta C(T)) method. Adults (white
bars) and neonates (black bars). All values represent means ± SD; SD of adult SeV group was ≤ 1.24. SD of neonatal groups was ≤ 1.10. *s =
0.007, **p = 0.030
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Page 2 of 12in both the adults and neonates peaked on day 3, and
levels remained equivalent on day 7. In both adults and
neonates, live infectious virus was not detectable by days
10 and 14 post-infection, suggesting that there was no
difference in viral clearance between the two groups.
Real-time PCR for SeV was performed and normalized
to GAPDH expression in the lung. This method also
demonstrated equivalent levels and clearance of SeV
RNA in both adult and neonatal lungs at all time points
through day 14 (Figure 1d).
Despite having equivalent levels of virus, the neonates
had significantly less inflammation in the lung during
SeV infection at all times post-infection (Figure 2a). In
order to determine if the level of inflammation corre-
lated with lung function, pulse oximetry was used to
measure oxygen saturation. Reduced oxygen saturation
was observed in the adult mice at the peak of infection,
but there was no loss of oxygen saturation in the neo-
nates. Thus, normal levels of oxygen saturation corre-
lated with the absence of inflammation in the lungs of
infected neonates (Figure 2b).
Total cell counts of bronchoalveolar lavage (BAL) fluid
showed that there was an increase of cells migrating
into the lungs of adult mice, but a minimal increase of
cells in the neonatal lungs during viral infection (Figure
3a). Differential cell counts (adjusted for total body
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Figure 2 Neonatal lungs had normal lung function and an absence of inflammatory cell influx. Adult and neonatal C57BL/6 mice were
infected as described in Figure 1. a) Lung sections of adult and neonatal mice at untreated day 0 and post-infection days 3, 7, and 10 were
stained with hematoxylin and eosin (magnification 200X). b) Oxygen saturation, as a measure of lung function, was analyzed using a mouse
pulse oximeter. Black squares denote adults inoculated with SeV (n = 6), white circles are UV-SeV inoculated neonates (n = 3), and black circles
are SeV inoculated neonates (n = 6). All values represent the mean ± SD; *p = 0.029
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Page 3 of 12weight) showed a predominantly neutrophilic influx in
the adult lungs that peaked at day 7. The total number
of neutrophils was lower in the neonatal lungs, although
the percentage of neutrophils in the BAL of adults and
neonates was similar (Figure 3b and 3c). Total macro-
phage and lymphocyte numbers were also increased in
the adult lungs compared to the neonates, but these
were not statistically signifi c a n t( d a t an o ts h o w n ) .T h e
neutrophil chemoattractant CXCL-2 (Macrophage
Inflammatory Protein-2; MIP-2) was significantly greater
in the adult lungs. CXCL-2 mRNA increased after infec-
tion in both the adults and neonates, and this increase
peaked in both groups on post-infection day 3 (Figure
3d). CXCL2 protein levels peaked in the neonate on day
5 post-infection, but were decreased on day 7. CXCL2
protein levels in the adult were significantly higher than
neonatal levels on days 3 and 7 (Figure 3e). In addition,
differential cytokine expression was observed between
the adults and neonates during the course of infection.
Both IFN-g and TNF-a increased during the course of
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Figure 3 Neutrophil influx and CXCL2 expression were lower in neonatal lungs. Adult and neonatal C57BL/6 mice were inoculated with
SeV 500 pfu/g body weight. a) On the indicated days, BAL was performed and total BAL fluid cells were counted. b) To enumerate the
neutrophils, BAL fluid cells were subjected to Wright Giemsa staining and differential cell counting. c) Percentage of neturophils of total BAL
cells. d) Whole lung RNA was analyzed by real-time PCR for CXCL2. *p < 0.05. Whole lung protein homogenates were analyzed for e) CXCL2, f)
IFN-g, g) TNF-a, and h) IL-6 protein by ELISA. *p < 0.05. White bars denote adults, and black bars denote neonates. N = 4 at each time point. All
values represent the mean ± SD
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Page 4 of 12infection in adult lungs. However, the levels of these
cytokines in neonatal lungs were significantly lower in
neonates on post-infection day 7 (Figure 3f and 3g). IL-
6 levels were upregulated by day 3 in adults and
remained elevated through day 7. However, the levels
were significantly lower in neonates at these times (Fig-
ure 3h). Thus, the increased CXCL2 levels as well as the
increased IFN-g, TNF-a and IL-6 corresponded with the
higher levels of inflammation in the adult lungs.
In order to compare the adult and neonatal
responses in a more comprehensive manner, a dose
response of viral infection was performed. Adult and
neonatal mice were infected with SeV at the doses of
50, 500, 5000 or 50,000 pfu/g body weight. The adult
mice showed the expected dose dependent decreases
in body weight during the first week of infection, and
the adults in the 50,000 pfu/g and 5,000 pfu/g groups
lost approximately 30% of their body weight by day 7
(Figure 4a). There was 100% survival of the adults in
the 50 and 500 pfu/g doses, but only 43% at the 5,000
pfu/g dose. None of the adults survived the highest
dose of 50,000 pfu/g beyond post-infection day 10. In
contrast, the neonatal mice continued to grow during
the first week post-infectio n .T h e r ew a sn od i f f e r e n c e
in the growth curve until day 11 when there was a sig-
n i f i c a n ts l o w i n go fg r o w t ho ft h en e o n a t e st h a t
received 5,000 pfu/g and 50,000 pfu/g doses of SeV
(Figure 4b). In addition, reduced survival was observed
in the neonatal mice in a dose dependent fashion (Fig-
ure 4d), and there was inflammation in the lungs at
the highest doses (Figure 5). Notably, even at these
higher doses, the inflammation in the neonates was
due to a differential cytokine expression pattern as
compared to adult lungs. On day 7 post-infection, pro-
tein levels of IFN-g,T N F - a, and CXCL2 in the adult
lung increased with higher doses of SeV. However, the
levels of IFN-g were significantly lower in the neonatal
lungs (Figure 4e), and TNF-a was at or below the level
of detection in the neonates at all doses of virus (Fig-
ure 4f). In addition, significantly higher CXCL2 protein
expression was observed in the adults (Figure 4g).
Thus, the inflammation that was present in the neo-
nates at the higher doses involved different cytokine
signals compared to the adult mice.
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Figure 4 Neonates had reduced expression of IFN-g,T N F - g and CXCL2 even at higher doses of virus. Adult (n = 3 for each dose) and
neonatal C57BL/6 mice (n = 6 for each dose) were infected with 50, 500, 5000, or 50,000 pfu SeV/g body weight. a) Body weight loss in adults
b) Body weights in neonates. White circles 50 pfu/g body weight, black circles 500 pfu/g, white squares 5,000 pfu/g, and black squares 50,000
pfu/g. c) Adult survival graph: white circles 50 pfu/g (n = 6), black circles 500 pfu/g (n = 6), white squares 5,000 pfu/g (n = 6) black squares
50,000 pfu/g (n = 6). d) Neonatal survival graph: white circles 50 pfu/g (n = 8), black circles 500 pfu/g (n = 9), white squares 5,000 pfu/g (n = 8)
black squares 50,000 pfu/g (n = 7). e) Post-infection day 7 IFN-g protein expression was determined by ELISA. *p < 0.05. f) Post-infection day 7
TNF-a protein expression was determined by ELISA. TNF-a proteins levels were below the level of detection in the neonatal samples at
inoculation doses of 500, 5000, and 50,000 pfu/g body weight (*none detected). g) Post-infection day 7 CXCL2 protein expression was
determined by ELISA. Adults (white bars); Neonates (black bars). Data are means ± SD.
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Page 5 of 12The reduced inflammatory influx into the neonatal
lungs during viral infection led us to hypothesize that
this could be due, in part, to decreased expression of
adhesion molecules. Real-time PCR for ICAM-1 mRNA
expression showed significantly reduced levels in
untreated neonates compared to untreated adults (Fig-
ure 6a). After viral infection, neonatal ICAM-1 mRNA
increased slightly, but was significantly lower than the
adult levels on post-infection days 3 and 5. Baseline
ICAM-1 protein expression was visualized by immunos-
taining. There was constitutive level of ICAM-1 protein
present in the parenchyma of untreated adult lungs (Fig-
ure 6b). In contrast, ICAM-1 protein is barely detectable
in the parenchyma of untreated neonatal lungs at day 0
(Figure 6c). The pattern of adult and neonatal ICAM-1
protein expression during the course of viral infection
was similar to ICAM-1 mRNA expression (data not
shown).
Because there was a difference in inflammation and
chemokine expression as early as 24 hours after infec-
tion, we hypothesized that the initial innate response to
SeV may be altered in neonatal lungs. Therefore, we
examined the expression of the pattern recognition
receptors for SeV, which included the Toll-like receptors
(TLR3, TLR7 and TLR8) and the RIG-I-like receptors
(Lgp-2, Mda-5, and RIG-I). Real-time PCR demonstrated
that there was no significant difference in mRNA
expression between adults and neonates for TLR3,
TLR7, and TLR8 at baseline. After SeV infection, TLR
levels in adults and neonates increase in a similar fash-
ion (Figure 7a). In contrast, analysis of the RLRs showed
delayed mRNA expression in the neonates for Lgp2,
Mda5, and RIG-I (Figure 7b). RLR expression in naïve
age-matched neonatal controls did not change during
the course of infection, suggesting that the increases in
RLR expression were due to viral infection and not
merely related to developmental changes. Western blot
analysis demonstrated the presence of low levels of RIG-
I protein in uninfected adult lungs, but RIG-I protein
was not detectable in uninfected neonatal lungs. RIG-I
protein increased in the adults on days 3, 5 and 7. RIG-I
protein levels also increased in neonatal lungs but this
increase was delayed (Figure 8a). In addition, a pattern
of delayed expression in neonatal lungs was observed
for Mda-5 protein (Figure 8a). No signal was detected in
western blot analysis of lung homogenates from naïve
age-matched neonatal controls (data not shown).
Because the RLRs activate type I interferons, we also
examined IFN-b mRNA expression. On post-infection
day 3 there was significantly reduced IFN-b mRNA
expression, but there was no difference at any of the
other time points (Figure 8b).
Discussion
In this study we developed a neonatal model of respira-
tory viral infection using the mouse pathogen Parain-
fluenza 1 virus strain Sendai/52 (Sendai virus; SeV),
which is closely related to RSV. SeV and RSV are both
enveloped RNA viruses and they share a highly con-
served genetic organization [12]. RSV infection in mice
does not resemble human RSV bronchiolitis for several
reasons (reviewed in [9]). First, RSV infects the airway
epithelial cells of humans, but it infects the type I alveo-
lar pneumocyte in the mouse resulting in pneumonia
rather than bronchiolitis [13,14]. Secondly, RSV does
not replicate well in mice. Inhibition of the interferon
50 pfu/g 500 pfu/g 5,000 pfu/g 50,000 pfu/g
Adult
Neonate
Figure 5 Neonatal lungs demonstrated inflammation at higher doses of SeV. Adult and neonatal mice were infected as described in Figure
4. Post-infection day 7 lungs were stained with hematoxylin and eosin (magnification 100X).
Bhattacharya et al. Virology Journal 2011, 8:549
http://www.virologyj.com/content/8/1/549
Page 6 of 12(IFN) antiviral response is important for paramyxo-
viruses to establish replication in the host cell. RSV con-
tains two non-structural proteins NS1 and NS2, which
antagonize interferon action by inhibiting STAT1 and
STAT2. The RSV NS1 and NS2 molecules are species
specific; thus, they can inhibit human STAT1 and
STAT2, but they do not inhibit the murine molecules
[15]. Finally, in contrast to human RSV infection, RSV
infection in mice elicits eosinophilic inflammation and a
T h 2c y t o k i n er e s p o n s e[ 1 6 ] .I nc o n t r a s tt om u r i n eR S V
infections, our previous studies have shown that SeV
infection of adult mice results in a neutrophilic bronch-
iolitis and immune response pattern that closely resem-
bles RSV infection in humans [17]. This data suggests
that SeV may be a useful model of paramyxoviral
infection.
We demonstrated that the neonatal innate immune
response to SeV was distinct from the adult response. In
adult mice, body weight loss correlated with peak levels
o fv i r u si nt h el u n g .I nc o n t r a s t ,t h eb o d yw e i g h ta n d
viral titer did not correlate in the neonates. Similar pat-
terns of body weight loss in adults and a later slowing
of growth in neonatal mice have been observed after
infection with RSV, Pneumonia virus of mice (PVM),
and the PR8 strain of influenza [10,11,18]. It is possible
that the differences of body weight patterns between
adults and neonates are reflective of distinct cytokine
expression. Some cytokines, including TNF-a,i n t e r l e u -
kin-1 (IL-1), IFN-g, and IL-6 have been implicated in
cachexia [19]. In our study, the adult mice have signifi-
cantly increased amounts of IFN-g and TNF-a,w h i c h
correlated with their weight loss. However, at higher
doses neonates had a slowing of growth (or failure to
thrive) after day 9 and this did not correlate with TNF-
a e x p r e s s i o n .I na d d i t i o n ,t h eu s eo fE n b r e lt ob l o c k
TNF-a during SeV infection in adult Stat1
-/- mice did
not affect body weight loss, suggesting that additional
cytokines may be responsible for body weight loss dur-
ing paramyxoviral infection [17].
Importantly, the neonates and adults had comparable
viral titers in the lungs, but the neonates exhibited sig-
nificantly less inflammation. These findings were also
consistent with observations made during infection of
murine neonates with the paramyxoviruses RSV and
PVM. However, neonatal mice infected with the ortho-
myxovirus influenza H1N1 (Strain A/PR/8/34) had a
delayed clearance of virus and increased numbers of
inflammatory cells in the interstitium [18]. Therefore,
these results of equivalent viral titers and reduced
inflammation in the neonates may be unique to para-
myxoviral infection.
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Figure 6 ICAM-1 mRNA and protein levels were lower in
neonatal lungs. a) Adult and neonatal C57BL/6 mice were infected
as described in Figure 1. Whole lung RNA from adults (white bars),
neonates (black bars), and naïve age-matched neonatal controls
(striped bars) was analyzed by qPCR for ICAM-1 mRNA levels. Data
are means ± SD. *p < 0.039. ICAM-1 immunostaining. Sections of
naïve day 0 untreated adult (b) and untreated neonatal lungs (c)
were stained with an anti-ICAM-1 antibody. Primary anti-ICAM-1
antibody was detected using an alkaline phosphatase red substrate
and the sections were counterstained with hematoxylin
(magnification 200X)
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Page 7 of 12SeV infection of the airway epithelium causes TNF-a
production, which results in the secretion of CXCL2
[17]. In this study, a dose response of SeV caused a
dose-dependent increase in TNF-a in the adult mice,
but not in the neonatal mice. As expected, the adult
mice also produced increased levels CXCL2, which
recruited neutrophils into the lungs. In contrast, the
neonates did not exhibit an increase in either TNF-a or
CXCL2 levels, and there was little to no recruitment of
PMN to the lungs. Both TNF-a and CXCL2 are known
to increase numbers of circulating neutrophils by releas-
ing them from the bone marrow reserve [20,21]. In
addition, neonates have quantitative defects of neutro-
phil storage pools as well as the capacity to generate
neutrophils [22]. Thus, the reduced numbers of PMN in
the neonatal lungs may be due to both reduced mobili-
zation from the storage pool and reduced chemokine
levels in the lung. Reduced TNF-a and chemokine levels
have also been observed in neonates infected with RSV
and PVM suggesting that this pattern is consistent in
the neonatal response to paramyxoviral infection [10,11].
Even with increased doses of SeV, there was differen-
tial cytokine expression in the neonates. The neonates
had significantly reduced levels of IFN-g even at 100-
fold higher inoculums of virus. This reduction in IFN-g
did not affect viral clearance in the neonates, which was
not unexpected because weight loss, mortality, histology,
and cytotoxic CD8+ T lymphocytes numbers were all
normal in SeV infected IFN-g deficient mice, suggesting
that IFN-g is not necessary for paramyxoviral clearance
[23,24]. IFN-g upregulates ICAM-1 expression on airway
epithelial cells both in vitro and in vivo [25]. In vitro
studies of airway epithelial cells have shown that ICAM-
1 expression is increased following paramyxoviral infec-
tion and necessary for leukocyte adherence and extrava-
sation [26]. Our observation of reduced ICAM-1
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Figure 7 TLR mRNA expression was similar in adult and neonatal lungs, but RLR mRNA expression was delayed in neonatal lungs.
Adult and neonatal C57BL/6 mice were infected as described in Figure 1. Whole lung RNA isolated from adults (white bars), neonates (black
bars) and naïve age-matched neonatal controls (striped bars) was analyzed by real-time PCR for TLR expression a) TLR-3, TLR-7, and TLR-8, and
RLR expression b) LGP2, MDA-5, and RIG-I. All values represent the mean ± SD; *, significant difference from corresponding adult sample.
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Page 8 of 12expression may be due to the reduced expression of
IFN-g in neonates. Consequently, the reduced expres-
sion of ICAM-1 may contribute to reduced inflamma-
tion in neonatal lungs. Previous studies demonstrated
that reduced inflammation in adult ICAM-1 knockout
mice protected them from weight loss, but did not
impair viral clearance, suggesting that inflammation is
not necessary for viral clearance [24].
When paramyxoviruses first infect the airway epithe-
lial cells they are detected by pattern recognition recep-
tors (PRR). The PRRs involved in detecting
paramyxoviral infection are the Toll-like receptors (the
TLRs including TLR-3, TLR-4, TLR-7, and TLR-8) and
the retinoic acid-inducible gene 1 (RIG-I)-like receptors
(RLRs including RIG-I, Mda-5 and Lgp2). TLR-4 is
expressed on the plasma membrane of epithelial cells
a n di tr e c o g n i z e st h ef u s i o n( F )p r o t e i no fh R S V[ 2 7 ] .
TLR-3, TLR-7 and TLR-8 are expressed intracellularly
on endosomes and they recognize dsRNA and ssRNA,
respectively [28-30]. RIG-I and MDA5 are cytoplasmic
pattern recognition receptors that recognize viral 5’ tri-
phosphate RNA [31,32]. They both contain a DEXD/H
helicase domain and 2 caspase-recruitment domains
(CARD). Lgp2 (laboratory of genetics and physiology 2)
is a helicase that is similar to RIG-I but it lacks the
CARD domain and may act as a regulator of RIG-I sig-
naling [33,34]. It has been shown that RIG-I is essential
for an appropriate immune response to both the para-
myxoviruses RSV and Sendai virus (SeV). In vitro, RIG-I
was necessary for type I IFN production in response to
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infection of airway epithelial cells inhibited both NFkB
and interferon regulatory factor (IRF) signaling [35].
Neonatal TLR responses of monocytes, conventional
dendritic cells, and plasmacytoid dendritic cells are dis-
tinct from the corresponding adult response to TLR sti-
mulation [36,37]. However, very little is known about
PRR expression and activation in neonatal lung during
respiratory viral infection. In the present studies, murine
neonates had normal expression of the TLRs in the lung
at baseline and during paramyxoviral infection; however,
all of the RLRs (Lgp2, Mda-5 and RIG-I) had signifi-
cantly delayed expression during infection. One study of
human infants examined PRR mRNA expression in
nasal washings of infants hospitalized with respiratory
viral bronchiolitis. There was no correlation of PRR
expression level and clinical severity score, but there
was a positive correlation between RSV viral load and
expression of RIG-I [38]. Our results show that RLR
expression increases in neonates during the course of
infection, so it is possible that these human samples
were taken when the infection was well established and
RIG-I was already upregulated. Thus, baseline expres-
sion of PRRs in human infants is still unknown.
Conclusions
In summary, our results established a model of para-
myxoviral infection that will aid in defining the unique
mechanisms of the neonatal immune response. Our data
showed that neonates have reduced inflammation in the
lungs compared to adults during SeV infection even
though both adult and neonatal lungs had a similar viral
load and clearance. The inflammation in the adult mice
was associated with higher levels of IFN-g and TNF-a
compared to the neonates. This suggests that the cyto-
kine milieu in the neonatal lungs is quite different from
the adults. In addition, the neonates have delayed
expression of the PRRs (RIG-I, MDa-5 and Lgp2), which
are essential for initiating the innate immune response.
Thus, our study with SeV, together with neonatal studies
of the related paramyxoviruses, RSV and PVM, all showed
reduced inflammatory cell influx in neonates compared to
the adults. In all three of these models, neonates were able
to control viral replication even with little to no inflamma-
tion in the lungs. It is suggested that a strong inflamma-
tory response is important for inhibiting viral replication,
the maturation of antigen presenting cells, and the devel-
opment of a vigorous T cell response. Inflammatory cyto-
kines are also necessary to activate and expand pathogen-
specific effector CD8
+ T lymphocytes [39]. Therefore,
future studies using this neonatal model will focus on how
this reduced inflammation may impact the development
of a protective memory response in neonates.
Methods
Mice and viral infection
Wild type C57BL/6 mice were obtained from Jackson
Laboratories. All mice were housed in pathogen-free
conditions in a biohazard barrier facility in micro-iso-
lator cages, and all procedures were reviewed and
approved by the Saint Louis University Animal Studies
Committee. Adult mice were anesthetized, and then
inoculated intranasally with 500 pfu/g body weight of
SeV, strain 52 (American Type Culture Collection) or
with UV-inactivated SeV (UV-SeV) in 30 μls t e r i l e
PBS. Two-day old neonatal mice were inoculated
intranasally with 500 pfu/g body weight in 6 μl sterile
PBS. After infection, mice underwent daily inspection
and body weight measurement. To determine lung
function, oxygen saturation was measured with the
MouseOx™ Pulse-oximeter according to manufac-
turer’s directions (Starr Life Sciences, Oakmont, PA).
Three minute readings were taken, readings with error
codes were eliminated, and the averages were calcu-
lated [40].
Bronchoalveolar lavage
Bronchoalveolar lavage was performed via tracheal can-
nulation with PBS containing 2% FBS. A volume of 1.0
ml was used for the adults and 0.3 ml was used for the
neonates. Total cell counts were determined after hypo-
tonic lysis to remove erythrocytes. To determine differ-
ential cell counts, cells were subjected to cytopsin
centrifugation and Wright-Giemsa staining.
Viral plaque assay
Lungs were weighed and homogenized in 1.0 ml sterile
1X PBS. Serial dilutions of lung homogenates were
adsorbed to LLC-MK2 cells for 90 minutes at 37°C with
rocking every 15 minutes. After adsorption, cells were
washed three times with 1X PBS and a 1% agarose over-
lay (Molecular Biology Grade, Thermo scientific) was
applied. The overlay contained Eagle’s Minimum Essen-
tial Medium (Lonza, Walkersville, MD), and 0.2 mg/ml
trypsin/EDTA (Sigma Aldrich, St. Louis, MO). After 5
days, the cells were fixed with 10% neutral buffered for-
malin and viral plaques were counted after crystal violet
staining. The number of viral plaques per ml were nor-
malized to total grams of lung tissue.
RNA analysis
Total RNA was isolated from lungs using the Illustra
RNAspin Mini RNA extraction kit (GE Healthcare,
Buckinghamshire, UK). The High Capacity Reverse
Transcription kit (Applied Biosystems, Carlsbad, CA)
was used to generate cDNA. Quantitative real-time PCR
was performed using the MJ Chromo 4 detection system
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Master Mix (Sigma Aldrich, St. Louis, MO). The specifi-
city of amplification was assessed for each sample by
dissociation curve analysis, and the size of the amplicon
was confirmed by agarose gel electrophoresis. Expres-
sion of each gene was normalized to GAPDH levels and
assessed using the 2(-Delta Delta C(T)) method [41].
The following primers were used to determine the
expression of the target genes: ICAM-1: forward, 5’-
CGC TGT GCT TTG AGA ACT GT -3’; reverse, 5’-
GGT GAG GTG CTT GCC TAC TT-3’;I F N - b:f o r -
ward, 5’- TCC AGC TCC AAG AAA GGA CGA ACA
-3’,r e v e r s e ,5 ’ - TCT GGA GCA TCT CTT GGA TGG
CAA - 3’;G A P D H :f o r w a r d ,5 ’- AGA TTG TCA GCA
ATG CAT CC -3’;r e v e r s e ,5 ’- ACA GTC TTC TGG
GTG GCA GT-3’;L G P 2 :f o r w a r d ,5 ’- AGC TGC TGA
TGC ATA ACC CAA AGC -3’;r e v e r s e ,5 ’-T G CT G C
TCA TAC ATC TGG GTT CCA - 3’; MDA-5: forward,
5’- CGA TCC GAA TGA TTG ATG CA - 3’;r e v e r s e ,
5’- AGT TGG TCA TTG CAA CTG CT - 3’;C X C L 2 :
forward, 5’ - AAA GTT TGC CTT GAC CCT GAA
GCC - 3’; reverse, 5’-T C CA G GT C AG T TA G CC T T
GCC TTT- 3’;R I G - I :f o r w a r d ,5 ’- AGA GAA TTC
GGC ACC CAG AA - 3’; reverse, 5’- AGC TCT CGC
TCG GTC TCA TC - 3’;S e V :f o r w a r d ,5 ’ -A T AC G G
CAA CCC AGA TGA AG - 3’; reverse, 5’-TCG AAC
AAG CTT AGC CCA GT - 3’;T L R - 3 :f o r w a r d ,5 ’-
GTG AGA TAC AAC GTA GCT GAC TG - 3’; reverse,
5’- TCC TGC ATC CAA GAT AGC AAG T- 3’; TLR-7:
forward, 5’- CGA TCC GAA TGA TTG ATG CA - 3’;
reverse, 5’- GGT AAG GGT AAG ATT GGT GGT G -
3’;T L R - 8 :f o r w a r d ,5 ’ - GAA AAC ATG CCC CCT
CAG TCA - 3’;r e v e r s e ,5 ’- CGT CAC AAG GAT AGC
TTC TGG AA - 3’.
Immunohistochemistry
Lungs were fixed in neutral buffered formalin (at 25 cm
water pressure), dehydrated in ethanol, embedded in
paraffin, and cut into 5 μm sections. Tissue sections
were blocked with normal goat serum and then incu-
bated with 1:500 dilution of hamster anti-mouse primary
anti-ICAM Ab (3E2 Pharmingen). Primary antibody was
detected with biotinylated goat anti-hamster IgG (1:200
dilution for 30 minute at room temperature) in 3% nor-
mal goat serum and the VECTASTAIN IN ABC-AP kit.
Slides were then stained with alkaline phosphatase red
substrate (Vector Laboratories) and counter stained with
hematoxylin.
ELISA
Lungs were homogenized in 1% Nonidet P-40, 0.05 M
Tris, pH 8.0, 250 mM NaCl, 1 mM EDTA containing
protease inhibitor cocktail (Sigma Aldrich, St. Louis,
MO). Total protein concentrations were determined
with Pierce BCA protein assay kit (Thermo Scientific,
Rockford, IL) and samples were normalized to equiva-
lent protein concentrations. Protein levels for IFN-g,
TNF-a, and IL-6 were measured using Ready-Set-Go
colorimetric sandwich ELISA kits (eBiosciences, San
Diego, CA. CXCL2 was measured using the Quantikine
Mouse CXCL2/MIP2 ELISA kit (R&D Systems, Minnea-
polis, MN).
Western blotting
Lungs were homogenized in 1% Nonidet P-40, 0.05 M
Tris, pH 8.0, 250 mM NaCL, 1 mM EDTA containing
protease inhibitor cocktail (Sigma Aldrich, St Louis,
MO), Total protein concentration were determined with
Pierce BCA protein assay kit (Thermo Scientific, Rock-
ford, IL). Primary antibodies were rat anti-mouse RIG-I
(Biolegend), rabbit anti-mouse Mda-5 (Cell Signaling),
and rabbit anti-mouse GAPDH (Cell Signaling). Second-
ary antibodies were HRP-conjugated goat anti-rat IgG
(Biolegend), goat anti-rabbit IgG (Cell Signaling), donkey
anti-rabbit IgG (Biolegend), respectively. Bands were
then visualized using Immobilon western chemilumi-
nenscent substrate kit (Millipore, Billerica, MA) and
imaged using Fujifilm corporation LAS-400 Chemilumi-
nescent imaging unit.
Statistical analysis
All values represent means ± standard deviation (SD).
Means were compared by a paired-samples t-test using
IBM
® SPSS
® Statistics Version 19. P values < 0.05 were
considered statistically significant.
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